Insider filings this week revealed a sharp split between buyers and sellers across US stocks.
The boldest move came from SMMT. Summit Therapeutics Chairman and CEO Robert Duggan filed on June 12 disclosing he bought $50M worth of shares at $13.12 each. That's 3.81 million shares added to his position — a major show of confidence from a top executive.
At FISV, five Fiserv insiders filed purchases in the last two days. The CFO, Chief Administration Officer, and three directors all bought shares near $49–51. The coordinated cluster buy is a notable signal. It suggests insiders see the recent dip as a buying opportunity.
On the selling side, DVA CEO Javier Rodriguez filed $14.5M in sales across two days. He unloaded shares at roughly $209 each on June 15 and 16. The Chief Legal Officer filed an additional $1.9M sale on the same dates.
QBTS CFO John Markovich has been steadily offloading D-Wave Quantum stock. He filed over $7.5M in sales in the past two weeks, selling tranches at prices ranging from $24 to $26.
The Walton Family Holdings Trust also filed the sale of $533M in stock this week — routine for the family, but large in dollar terms.
This article is for informational purposes only and does not constitute financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.